GAPDH and Parkinson disease: Moreover, it was shown that that deprenyl (a drug that ameliorates the progression of Parkinson’s disease) and other structurally related propargylamines bind with GAPDH and increase neuronal survival by interfering with apoptosis signaling pathways [37].